Results 101 to 110 of about 40,749 (237)

A review of the safety of sodium‐glucose co‐transporter‐2 inhibitors

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract The development of sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors represents a major turning point in the effort to preserve kidney function and prevent cardiovascular events and heart failure hospitalisations in those at high risk. These agents have now transcended their original glucose‐lowering indication and provide a range of clinical
Daniel Vincent O'Hara, Meg J. Jardine
wiley   +1 more source

Real world evidence of insulin and biosimilar insulin therapy—Opportunities to improve adherence, outcomes and cost‐effectiveness

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Insulin has been discovered for more than a century; however, its benefits to people with diabetes are yet to be fully realized due to barriers related to access, quality of care and costs. Insulin therapy remains the cornerstone of diabetes management. The multicausality of diabetes and its subtypes calls for comprehensive phenotyping and use
Aimin Yang   +4 more
wiley   +1 more source

Type 1 diabetes presenting in adults: Trends, diagnostic challenges and unique features

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Type 1 diabetes (T1D) has been historically regarded as a childhood‐onset disease; however, recent epidemiological data indicate that adult‐onset T1D accounts for a substantial proportion of cases worldwide. There is evidence that adult‐onset T1D is associated with the classic T1D triad of elevated genetic risk, the presence of islet‐specific ...
Carmella Evans‐Molina, Richard A. Oram
wiley   +1 more source

Diabetic Ketoacidosis in Children - An Experience in a Tertiary Hospital

open access: bronze, 1970
Bedowra Zabeen   +4 more
openalex   +2 more sources

Heterogeneity in the management of diabetic ketoacidosis in Australia: a national survey

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background Diabetic ketoacidosis (DKA) is a hyperglycaemic emergency, and insulin administration is highly protocolised with either variable‐ or fixed‐rate intravenous infusions. There are limited data supporting superiority of one regimen over another; however, international guidelines recommend fixed‐rate infusions.
Lisa M. Raven   +6 more
wiley   +1 more source

Editorial: COVID-19 and diabetes, volume II

open access: yesFrontiers in Endocrinology, 2023
Hamad Ali   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy